Stock NVNO ENVVENO MEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar enVVeno Medical Corporation

Equities

NVNO

US29415J1060

Market Closed - Nasdaq
Other stock markets
 21:00:00 29/04/2024 BST 		5-day change 1st Jan Change
5.22 USD +0.77% Intraday chart for enVVeno Medical Corporation +6.31% +1.56%
04-16 EnVVeno Medical Corporation Announces Additional Topline Efficacy Data from the VenoValve U.S. Pivotal Trial to Be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 CI
04-09 EnVVeno Medical Corporation Appoints Andrew Cormack as Its Chief Commercial Officer CI

Chart calendar enVVeno Medical Corporation

9b1e8f7a0716c44380e699c60a3.GsUJhVDN86aos_3V6pLgJKFyv763Fp0Bh_hOfxEJrJI.doxT8j6pkfHQ2JutpuHNCZQA-u2EVdBP15YRGGNOyv9Fh1G0M5yin-fDig~cde70e6985e9f63ef6bb3bb2b5d8d4ac

Upcoming events on enVVeno Medical Corporation

06/11/2024 Q3 2024 Earnings Release (Projected)
04/05/2025 Q1 2025 Earnings Release (Projected)

Past events on enVVeno Medical Corporation

28/04/2024 Q1 2024 Earnings Release (Projected)
23/04/2024 Charing Cross International Symposium - Dr. David Dexter
06/03/2024 18:30 American Venous Forum
04/12/2023 Annual General Meeting
15/11/2023 VEITH Symposium
26/10/2023 13:05 Q3 2023 Earnings Release
25/10/2023 17:00 Investor Ask the CEO Conference
01/08/2023 Q2 2023 Earnings Release (Projected)
18/07/2023 20:00 Investor Meeting - Key Opinion Leader
13/07/2023 17:00 Summer Spotlight Series Investor Conference
01/05/2023 13:00 Q1 2023 Earnings Release
08/03/2023 14:10 Cowen Health Care Conference
01/03/2023 Q4 2022 Earnings Release
19/01/2023 18:00 Virtual Investor 2023 Companies to Watch
29/11/2022 Annual General Meeting
10/11/2022 20:05 Q3 2022 Earnings Release
29/09/2022 19:00 Ladenburg Thalmann Healthcare Conference - Fireside Chat
21/09/2022 21:30 Business Update Call
12/09/2022 12:00 H.C. Wainwright Global Investment Conference
03/08/2022 21:45 Interim 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,03
0,03
0.77%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-7,68
-7,76
1.1%		-9,14
-7,04
-29.76%		-16,9
-12,6
-34.17%		-24,9
-25,2
1.14%		-25,2
-26,7
5.48%
-25,8

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,63
-7,72
1.21%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

Net income
Million USD		Released
Forecast
Spread 		-7,63
-7,72
1.21%		-9,74
-6,70
-45.41%		-16,5
-12,4
-33.4%		-24,7
-25,3
2.46%		-23,5
-26,1
9.8%
-26,1

EPS
USD		Released
Forecast
Spread 		-12,0
-12,3
2.04%		-7,54
-0,34
-2117.65%		-1,90
-1,37
-38.69%		-2,20
-2,21
0.45%		-1,91
-2,07
7.73%
-1,40

Announcement Date18/03/2031/03/2128/03/2202/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,60

EBIT
Million USD		Released
Forecast
Spread 		-8,99
-4,10
-119.32%		-5,34
-3,72
-43.41%		-6,99
-3,94
-77.31%		-6,15
-5,98
-2.86%		-6,46
-6,75
4.3%		-6,80
-6,38
-6.54%		-6,81
-6,55
-4.03%		-5,35
-6,44
16.94%		-6,28
-6,65
5.59%
-6,60


-6,64


-5,94


-6,65


-6,89

Net income
Million USD		Released
Forecast
Spread 		-8,99
-4,02
-123.58%		-5,33
-3,78
-41.01%		-7,06
-3,99
-76.99%		-6,10
-6,04
-0.94%		-6,18
-6,80
9.12%		-6,39
-6,44
0.75%		-6,47
-6,61
2.06%		-5,00
-6,49
22.94%		-5,65
-6,71
15.81%
-6,66


-6,70


-6,00


-6,71


-6,95

EPS
USD		Released
Forecast
Spread 		-0,94
-0,33
-184.85%		-0,47
-0,29
-62.07%		-0,63
-0,33
-90.91%		-0,54
-0,52
-3.85%		-0,55
-0,57
3.51%		-0,57
-0,48
-18.75%		-0,58
-0,49
-18.37%		-0,45
-0,48
6.25%		-0,32
-0,46
30.43%
-0,40


-0,36


-0,31


-0,34


-0,33

Announcement Date28/03/2229/04/2203/08/2227/10/2202/03/2328/04/2331/07/2326/10/2329/02/24-----

Upcoming sector events for enVVeno Medical Corporation

30/04/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
01/05/2024 11:30 UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release
01/05/2024 11:30 BIO-TECHNE CORPORATION: Q3 2024 Earnings Release
01/05/2024 12:00 ALKERMES PLC: Q1 2024 Earnings Release
01/05/2024 VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
01/05/2024 CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for enVVeno Medical Corporation

Today CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
29/04/2024 21:05 QIAGEN N.V.: Q1 2024 Earnings Release
29/04/2024 21:01 MORPHOSYS AG: Q1 2024 Earnings Release
28/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
27/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
26/04/2024 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00 BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NVNO Stock
  4. Calendar enVVeno Medical Corporation